Profound Medical Corp.
PRN.TO
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -20.73% | -22.64% | |||
| Total Other Revenue | -13.33% | -31.91% | |||
| Total Revenue | -15.64% | -29.26% | |||
| Cost of Revenue | -22.79% | -34.97% | |||
| Gross Profit | -12.68% | -26.58% | |||
| SG&A Expenses | 13.58% | 24.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.17% | 10.61% | |||
| Operating Income | -23.64% | -27.48% | |||
| Income Before Tax | -46.32% | -91.73% | |||
| Income Tax Expenses | 56.10% | 117.23% | |||
| Earnings from Continuing Operations | -46.35% | -101.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -46.35% | -101.05% | |||
| EBIT | -23.64% | -27.48% | |||
| EBITDA | -24.19% | -31.22% | |||
| EPS Basic | -46.27% | -72.46% | |||
| Normalized Basic EPS | -46.24% | -64.54% | |||
| EPS Diluted | -46.27% | -72.46% | |||
| Normalized Diluted EPS | -46.24% | -64.54% | |||
| Average Basic Shares Outstanding | 0.04% | 16.57% | |||
| Average Diluted Shares Outstanding | 0.04% | 16.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||